Dr. Nicola Mulholland is a Consultant Clinical Radiologist and Nuclear Medicine Physician specialising in radionuclide radiotherapy, functional imaging with PETCT& WBMRI, cross-sectional radiology, and cancer.

She studied medicine at Univerisity of Cambridge and the University of London, qualifying with distinction in medicine and pathology in 1995. She became a Fellow of the Royal College of Physicians in 1999. She also became a Fellow of the Royal College of Radiologists in 2004. She completed dual training in clinical radiology at King's College Hospital and nuclear medicine at Guy's and St Thomas Hospital in London and was registered by the General Medical Council as a specialist in March and December of 2007.

Dr. Mulholland offers molecular radiotherapy including radioiodine therapy for thyroid disease ( thyrotoxicosis), PRRT for NET (Lutathera) RLT for prostate cancer (Pluvicto) and selective internal radioembolization therapy for liver cancer. She has a high level of expertise in hybrid imaging, including PET-CT and SPECT-CT as well as expertise in MRI, cardiac CT angiography, and haemato-oncology.

Dr. Mulholland is the Clinical Director of Cancer and head of nuclear medicine and PETCT dept at Kings College Hospital.

She is an Honorary Senior Lecturer at King's College London.

She has research interests in the use of imaging biomarkers in haemato-oncology and novel molecular radiotherapy techniques.